https://www.selleckchem.com/pr....oducts/Nanchangmycin
This article reviews advances over the past 3years in cardiac magnetic resonance (CMR) imaging in pulmonary hypertension (PH). We aim to bring the reader up-to-date with CMR applications in diagnosis, prognosis, 4D flow, strain analysis, T mapping, machine learning and ongoing research. CMR volumetric and functional metrics are now established as valuable prognostic markers in PH. This imaging modality is increasingly used to assess treatment response and improves risk stratification when incorporated into PH risk scores. Emerging
Like
Comment
Share
